Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Introduction to Biological Bases of Psychology01:30

Introduction to Biological Bases of Psychology

Biopsychology serves as a vital bridge connecting the intricate domains of biology and psychology, shedding light on how biological systems influence psychological phenomena. This field scrutinizes the biological substrates of behavior and mental processes, emphasizing the nervous system along with the roles of neurotransmitters, hormones, and genetics. It also incorporates evolutionary perspectives to explain the adaptive nature of mental functions.
The nervous system, the cornerstone of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fructooligosaccharide supplementation ameliorates gut associated metabolic dysregulation in estrogen-deprived rats via targeting oxidative stress, inflammation, apoptosis, and gut microbiome.

Scientific reports·2026
Same author

Role of Brown Adipose Tissue-Specific Sympathetic and Sensory Innervations in Menthol-Induced Energy-Expending Phenotype.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Thermosensitive TRP channels as dietary modulators of adipose thermogenesis: Implications for energy homeostasis and obesity.

Journal of thermal biology·2026
Same author

Beneficial Modulation of the Microbiota-Gut-Brain Axis by Supplementation with Modified Kodo Millet Bran and a GABA-Producing Bacterium in PTZ-Induced Kindling.

Probiotics and antimicrobial proteins·2026
Same author

β-glucuronidase: potential target for postmenopausal gut dysbiosis in Estrogen deficient chronic unpredictable mild stressed rats.

Molecular biology reports·2026
Same author

Fructooligosaccharide ameliorates estrogen-gut-microbiome-brain axis dysfunction in estrogen-deficient rats.

Food & function·2026

Related Experiment Video

Updated: Jun 5, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Pathobiological targets of depression.

Kanwaljit Chopra1, Baldeep Kumar, Anurag Kuhad

  • 1Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study, Panjab University, Chandigarh-160014, India. dr_chopra_k@yahoo.com

Expert Opinion on Therapeutic Targets
|January 25, 2011
PubMed
Summary

Depression affects 21% of the global population. Future depression treatments may target pathways beyond monoamines, such as NO and cytokines, offering new therapeutic options.

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Related Experiment Videos

Last Updated: Jun 5, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Depression is a widespread mental illness causing significant disability and mortality, affecting approximately 21% of the global population.
  • Pathological factors include the monoamine hypothesis, neurotrophic factor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis dysregulation, oxidative stress, cytokine hypothesis, and the nitric oxide (NO) pathway.

Purpose of the Study:

  • To review recently discovered pathogenetic hypotheses of mental depression.
  • To explore current and potential future therapeutics for depression.
  • To discuss various evaluation models for antidepressant drugs.

Main Methods:

  • Literature review focusing on recent pathogenetic hypotheses and therapeutic strategies for depression.
  • Analysis of established and emerging biological pathways implicated in depression.
  • Examination of current antidepressant drug classes, including selective serotonin re-uptake inhibitors and norepinephrine-dopamine re-uptake inhibitors.

Main Results:

  • The hypothalamic-pituitary-adrenal (HPA) axis dysregulation, influenced by stress, is a key factor in depressive disorder development.
  • Cytokine effects on behavior are linked to neurotransmitter function, synaptic plasticity, and neuroendocrine regulation.
  • Current antidepressants primarily target the monoaminergic pathway, but other pathways are under investigation.

Conclusions:

  • While stress-induced HPA axis dysregulation contributes to depression, current treatments largely focus on monoaminergic pathways.
  • Emerging research suggests that targeting NO, cytokines, and the kynurenine acid pathway holds significant therapeutic potential for future depression treatments.